Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.4M Buy
25,959
+1,113
+4% +$381K 0.11% 101
2026
Q1
$8.74M Sell
24,846
-85
-0.3% -$30.3K 0.11% 100
2025
Q4
$8.16M Sell
24,931
-225
-0.9% -$71.4K 0.1% 104
2025
Q3
$7.1M Sell
25,156
-278
-1% -$80.6K 0.09% 112
2025
Q2
$7.1M Buy
25,434
+309
+1% +$87.5K 0.09% 112
2025
Q1
$7.83M Sell
25,125
-500
-2% -$148K 0.1% 104
2024
Q4
$6.68M Buy
25,625
+70
+0.3% +$20.8K 0.09% 109
2024
Q3
$8.23M Sell
25,555
-370
-1% -$121K 0.1% 107
2024
Q2
$8.18M Sell
25,925
-37
-0.1% -$10.9K 0.11% 103
2024
Q1
$7.38M Buy
25,962
+296
+1% +$86.6K 0.1% 109
2023
Q4
$7.39M Sell
25,666
-15
-0.1% -$4.09K 0.11% 106
2023
Q3
$6.9M Sell
25,681
-2,982
-10% -$744K 0.11% 108
2023
Q2
$6.36M Sell
28,663
-137
-0.5% -$31.8K 0.1% 113
2023
Q1
$6.96M Sell
28,800
-397
-1% -$97.5K 0.12% 108
2022
Q4
$7.67M Sell
29,197
-79
-0.3% -$21.2K 0.14% 106
2022
Q3
$6.6M Sell
29,276
-1,184
-4% -$287K 0.13% 113
2022
Q2
$7.41M Sell
30,460
-711
-2% -$174K 0.14% 111
2022
Q1
$7.54M Sell
31,171
-110
-0.4% -$25.3K 0.12% 120
2021
Q4
$7.04M Sell
31,281
-3,617
-10% -$763K 0.11% 126
2021
Q3
$7.42M Sell
34,898
-1,421
-4% -$327K 0.12% 117
2021
Q2
$8.85M Buy
36,319
+360
+1% +$88.6K 0.15% 112
2021
Q1
$8.95M Sell
35,959
-1,449
-4% -$346K 0.17% 108
2020
Q4
$8.6M Sell
37,408
-432
-1% -$99.6K 0.17% 105
2020
Q3
$9.62M Sell
37,840
-659
-2% -$163K 0.21% 95
2020
Q2
$9.08M Sell
38,499
-1,558
-4% -$355K 0.21% 93
2020
Q1
$8.12M Buy
40,057
+5,573
+16% +$1.22M 0.23% 92
2019
Q4
$8.31M Buy
34,484
+140
+0.4% +$30.9K 0.19% 107
2019
Q3
$6.65M Buy
34,344
+268
+0.8% +$51.4K 0.16% 115
2019
Q2
$6.28M Sell
34,076
-40
-0.1% -$7.16K 0.15% 118
2019
Q1
$6.48M Sell
34,116
-4,710
-12% -$899K 0.16% 115
2018
Q4
$7.56M Sell
38,826
-828
-2% -$162K 0.21% 103
2018
Q3
$8.22M Sell
39,654
-345
-0.9% -$68K 0.2% 111
2018
Q2
$7.38M Sell
39,999
-29
-0.1% -$5.13K 0.19% 110
2018
Q1
$6.82M Sell
40,028
-1,362
-3% -$250K 0.18% 117
2017
Q4
$7.2M Buy
41,390
+79
+0.2% +$14K 0.19% 108
2017
Q3
$7.7M Sell
41,311
-819
-2% -$145K 0.2% 109
2017
Q2
$7.26M Buy
42,130
+268
+0.6% +$43.6K 0.2% 113
2017
Q1
$6.87M Buy
41,862
+630
+2% +$105K 0.2% 115
2016
Q4
$6.03M Buy
+41,232
New +$6.21M 0.18% 119
2016
Q3
Sell
-39,935
Closed -$6.08M 314
2016
Q2
$6.08M Buy
39,935
+150
+0.4% +$23.3K 0.19% 110
2016
Q1
$5.96M Sell
39,785
-528
-1% -$78.4K 0.19% 117
2015
Q4
$6.54M Buy
40,313
+875
+2% +$138K 0.21% 108
2015
Q3
$5.46M Sell
39,438
-2,340
-6% -$369K 0.18% 114
2015
Q2
$6.41M Sell
41,778
-1,349
-3% -$216K 0.2% 110
2015
Q1
$6.89M Sell
43,127
-1,875
-4% -$295K 0.21% 109
2014
Q4
$7.17M Sell
45,002
-1,558
-3% -$243K 0.21% 111
2014
Q3
$6.54M Buy
+46,560
New +$6.08M 0.2% 112
2014
Q2
Sell
-46,262
Closed -$5.71M 333
2014
Q1
$5.71M Sell
46,262
-1,148
-2% -$139K 0.18% 116
2013
Q4
$5.41M Sell
47,410
-495
-1% -$56.3K 0.17% 116
2013
Q3
$5.36M Buy
47,905
+1,429
+3% +$155K 0.18% 113
2013
Q2
$4.58M Buy
+46,476
New +$4.82M 0.16% 116

Other funds holding AMGN

Welch & Forbes's AMGN Position: Q2 2026 in Review

Welch & Forbes increased its Amgen (AMGN) stake by 4.5% in Q2 2026, buying an estimated $381K and bringing the position to 25,959 shares worth $9.4M. The position accounts for 0.11% of the portfolio, ranked #101.

Welch & Forbes first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $9.62M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Welch & Forbes held 25,959 shares of Amgen worth $9.4M as of Q2 2026.
  • Welch & Forbes bought 1,113 Amgen shares in Q2 2026, an estimated $381K.
  • Amgen made up 0.11% of Welch & Forbes's portfolio in Q2 2026, its #101 holding.
  • Welch & Forbes first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Welch & Forbes's Amgen position peaked at $9.62M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.